Résumé Les neuroblastomes de haut risque représentent près de la moitié des cas de
neuroblastome et leur survie à long terme est inférieure à 50% malgré des traitements …

High-risk neuroblastoma comprises nearly half of cases of neuroblastoma and the long-term
survival is less than 50% despite complex and intensive treatments. Studies conducted in …

Le neuroblastome de stade 4 est une tumeur maligne dont le pronostic à moyen et à long
terme reste préoccupant malgré les progrès thérapeutiques. Notre étude a pour objectif …

Le neuroblastome est remarquable par la diversité de ses présentations, depuis les formes
régressant spontanément jusqu'aux tumeurs progressant rapidement vers le décès de …

Neuroblastoma is the most common extra-cranial solid tumor of childhood and the most
common in the first year of life. It is a unique malignancy in that infants often present with …

Background: Neuroblastoma (NBL) accounts for 8% to 10% of all childhood cancers, and
more than half of these cases are advanced stages. Vigorous research on single, tandem or …

High-risk neuroblastoma comprises nearly half of all neuroblastoma and have a long-term
survival of< 50%. Patients> 18 months with International Neuroblastoma Staging System …

Neuroblastomas are tumours of sympathetic origin, with a heterogeneous clinical course
ranging from localized or spontaneously regressing to widely metastatic disease …

Background The survival rate among patients with intermediate-risk neuroblastoma who
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …

Close international collaboration between pediatric oncologists has led to marked
improvements in the cure of patients, seen as a long-term overall survival rate of about 80 …